Cargando…
A Radiomics-Clinical Model Predicts Overall Survival of Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: A Multicenter Study
SIMPLE SUMMARY: In the recent years, immune checkpoint inhibitors (ICIs) have significantly modified non-small cell lung cancer (NSCLC) treatment by providing new therapeutic avenues with superior efficacy and improved tolerability over traditional cytotoxic therapies. The immune activation can lead...
Autores principales: | Yolchuyeva, Sevinj, Giacomazzi, Elena, Tonneau, Marion, Ebrahimpour, Leyla, Lamaze, Fabien C., Orain, Michele, Coulombe, François, Malo, Julie, Belkaid, Wiam, Routy, Bertrand, Joubert, Philippe, Manem, Venkata S. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417039/ https://www.ncbi.nlm.nih.gov/pubmed/37568646 http://dx.doi.org/10.3390/cancers15153829 |
Ejemplares similares
-
Radiomics approaches to predict PD-L1 and PFS in advanced non-small cell lung patients treated with immunotherapy: a multi-institutional study
por: Yolchuyeva, Sevinj, et al.
Publicado: (2023) -
Generalization optimizing machine learning to improve CT scan radiomics and assess immune checkpoint inhibitors’ response in non-small cell lung cancer: a multicenter cohort study
por: Tonneau, Marion, et al.
Publicado: (2023) -
Characterization and description of Gabonibacter chumensis sp. nov., isolated from feces of a patient with non-small cell lung cancer treated with immunotherapy
por: Diop, Khoudia, et al.
Publicado: (2023) -
Helicobacter pylori serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors
por: Tonneau, Marion, et al.
Publicado: (2022) -
Unravelling actionable biology using transcriptomic data to integrate mitotic index and Ki-67 in the management of lung neuroendocrine tumors
por: Manem, Venkata S.K., et al.
Publicado: (2021)